DR. HEXEBERGS KLINIKK AS
Dr. Hexeberg | MATVAREINTOLERANSER OG MAGE-/TARMSYKDOMMER
Dr. Hexeberg, Klinikken baserer seg på å bruke mat som medisin med fokus på et individuelt tilpasset kosthold. Erfaringene vi har gjort i årene siden 2010 har gjort at vi har fått erfaring fra et større spekter av diagnoser / problemstillinger og en større forståelse for et individuelt tilpasset kosthold. Vi anbefaler også tilskudd av vitaminer og mineraler og eventuelt medikamenter når vi synes dette er nødvendig. MATVAREINTOLERANSER OG MAGE-/TARMSYKDOMMER behandles ofte med råd fra oss.
Organization
- CEO
- EH
Erik Hexeberg1957
- Chairman of the board
- EH
Erik Hexeberg1957
- Years since formation
- 15 years
- since Nov 16, 2010
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 7,207,730
- NOK
- Annual total result 2024
- -120,892
- NOK
- Total equity 2024
- 350,158
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
EH 1957 | Managing Director/CEO | 50 % indirectly |
Board
Name | Role | Shares |
---|---|---|
EH 1957 | Chairman | 50 % indirectly |
SH 1960 | Alternate Member | 50 % indirectly |
Others
Name | Role | Shares |
---|---|---|
Auditor | - | |
Accountant | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
EH 1957 | Managing Director/CEO, Chairman | 50 % indirectly |
SH 1960 | Alternate Member | 50 % indirectly |
Last update: Aug 26, 2025
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 100 | 100 % |
Shares owned by the DR. HEXEBERGS KLINIKK AS
Name | Share class | Total number of shares | Share |
---|---|---|---|
Ordinary shares | 5,371 | 4.55 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 2,778,762Operating profit 2024: NOK 343,599Employees: 0
Financials
in NOK
Summary
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 7,207,730 | 5,381,691 | 3,313,050 | 2,946,219 |
Annual Total Result | -120,892 | 439,974 | 456,429 | -67,123 |
Total assets | 1,472,681 | 798,127 | 488,391 | 242,473 |
Total liabilities | 1,122,523 | 461,387 | 591,625 | 802,135 |
Total equity | 350,158 | 336,740 | -103,234 | -559,662 |
P&L
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total operating income | 7,207,730 | 5,381,691 | 3,313,050 | 2,946,219 |
Total operating costs | 7,329,258 | 4,817,283 | 2,751,572 | 3,012,678 |
Operating result | -121,528 | 564,408 | 561,478 | -66,459 |
Financial income/costs | 636 | -975 | -3,233 | -664 |
Profit before tax | -120,892 | 563,433 | 558,246 | -67,123 |
Total tax & extraordinary income/cost | 0 | 123,459 | 101,817 | 0 |
Annual Total Result | -120,892 | 439,974 | 456,429 | -67,123 |
Balance overview
Year | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total fixed assets | 229,694 | 236,324 | 6,000 | 6,000 |
Total current assets | 1,242,988 | 561,803 | 482,391 | 236,473 |
Total assets | 1,472,681 | 798,127 | 488,391 | 242,473 |
Short term debt | 1,022,523 | 361,387 | 491,625 | 702,135 |
Long term debt | 100,000 | 100,000 | 100,000 | 100,000 |
Total liabilities | 1,122,523 | 461,387 | 591,625 | 802,135 |
Contributed capital | 234,310 | 100,000 | 100,000 | 100,000 |
Retained earnings | 115,848 | 236,740 | -203,234 | -659,662 |
Total equity | 350,158 | 336,740 | -103,234 | -559,662 |
Total equity and liabilities | 1,472,681 | 798,127 | 488,391 | 242,473 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises